Milena Villarroel
Overview
Explore the profile of Milena Villarroel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gregianin L, Rose A, Villarroel M, Almeida M, Siqueira L, Salgado C, et al.
Pediatr Blood Cancer
. 2025 Jan;
72(4):e31554.
PMID: 39838616
Background: GALOP investigators developed a prospective cooperative protocol for localized Ewing sarcoma (ES) incorporating interval-compressed chemotherapy (VDC/IE, vincristine, doxorubicin, cyclophosphamide/ifosfamide and etoposide). After completing conventional treatment, patients were randomized to...
2.
Valenzuela R, Santolaya M, Villarroel M, Cavada G, Alfaro T
Andes Pediatr
. 2025 Jan;
95(5):583-592.
PMID: 39760628
Objective: To estimate 5-year survival in pediatric cancer patients affected by FN, according to clinical-demographic variables. Patients And Method: Survival, prognostic, and analytical study with historical cohort. analytical. Cancer was...
3.
Gorostegui-Obanos M, Chantada L, Filho N, Gonzalez-Ramella O, Serrano B M, Valencia D, et al.
Pediatr Blood Cancer
. 2024 Aug;
71(11):e31262.
PMID: 39133030
Background: The International Society of Paediatric Oncology Society Global Mapping Program aims to describe the local pediatric oncology capacities. Here, we report the data from Latin America. Methods: A 10-question...
4.
Barraza M, Valenzuela R, Villarroel M, De la Maza V, Contardo V, Alvarez A, et al.
Mycoses
. 2024 Aug;
67(8):e13780.
PMID: 39132817
Background: Invasive fungal diseases (IFD) are high morbidity and mortality infections in children with cancer suffering episodes of high-risk febrile neutropenia (HRFN). IFD epidemiology has changed in the last two...
5.
Torres J, Ibanez C, Valenzuela R, Rivera S, De la Maza V, Villarroel M, et al.
Clin Microbiol Infect
. 2024 Apr;
30(8):1029-1034.
PMID: 38648896
Objectives: To validate the efficacy and safety of withholding antimicrobial therapy in a new cohort of children with cancer and febrile neutropenia (FN) having a demonstrated viral respiratory tract infection....
6.
Cappellano A, Gorostegui M, Gonzalez-Ramella O, Filho N, Valencia D, Chantada L, et al.
Pediatr Blood Cancer
. 2024 Apr;
71(6):e30973.
PMID: 38556746
Background: Latin American countries are improving childhood cancer care, showing strong commitment to implement the Global Initiative for Childhood Cancer, but there are scant publications of the situation at a...
7.
Villanueva G, Lowe J, Tentoni N, Taluja A, Villarroel M, Narvaez C, et al.
Pediatr Hematol Oncol
. 2023 Oct;
41(2):135-149.
PMID: 37865916
High-dose methotrexate (HDMTX) is used to treat a broad spectrum of cancers. Methotrexate (MTX) monitoring and adequate supportive care are critical for safe drug administration; however, MTX level timing is...
8.
Impact of COVID-19 in pediatric oncology care in Latin America during the first year of the pandemic
Villanueva G, Sampor C, Palma J, Villarroel M, Valencia D, Garcia Lombardi M, et al.
Pediatr Blood Cancer
. 2022 May;
69(10):e29748.
PMID: 35593012
Background: The ongoing coronavirus 2019 disease (COVID-19) pandemic strained medical systems worldwide. We report on the impact on pediatric oncology care in Latin American (LATAM) during its first year. Method:...
9.
Major A, Palese M, Ermis E, James A, Villarroel M, Klussmann F, et al.
JCO Glob Oncol
. 2022 Feb;
8:e2100266.
PMID: 35157510
Purpose: The global pediatric oncology clinical research landscape, particularly in Central and South America, Africa, and Asia, which bear the highest burden of global childhood cancer cases, is less characterized...
10.
Tapia L, Olivares M, Torres J, De la Maza V, Valenzuela R, Contardo V, et al.
Cytokine
. 2021 Jun;
148:155619.
PMID: 34134910
Background: In children with cancer and persistent high-risk febrile neutropenia (HRFN), cytokines/chemokines profiles can guide the differentiation of febrile neutropenia (FN) due to infections and episodes of unknown origin (FN-UO)....